These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14523271)

  • 1. Detection of high frequencies of HIV-1 cross-subtype reactive CD8 T lymphocytes in the peripheral blood of HIV-1-infected Kenyans.
    Currier JR; Dowling WE; Wasunna KM; Alam U; Mason CJ; Robb ML; Carr JK; McCutchan FE; Birx DL; Cox JH
    AIDS; 2003 Oct; 17(15):2149-57. PubMed ID: 14523271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8(+) T-cell gamma interferon production specific for human immunodeficiency virus type 1 (HIV-1) in HIV-1-infected subjects.
    Huang XL; Fan Z; Kalinyak C; Mellors JW; Rinaldo CR
    Clin Diagn Lab Immunol; 2000 Mar; 7(2):279-87. PubMed ID: 10702505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection.
    Wilson SE; Pedersen SL; Kunich JC; Wilkins VL; Mann DL; Mazzara GP; Tartaglia J; Celum CL; Sheppard HW
    AIDS Res Hum Retroviruses; 1998 Jul; 14(11):925-37. PubMed ID: 9686639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response.
    Currier JR; Visawapoka U; Tovanabutra S; Mason CJ; Birx DL; McCutchan FE; Cox JH
    BMC Immunol; 2006 Apr; 7():8. PubMed ID: 16620386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients.
    Durali D; Morvan J; Letourneur F; Schmitt D; Guegan N; Dalod M; Saragosti S; Sicard D; Levy JP; Gomard E
    J Virol; 1998 May; 72(5):3547-53. PubMed ID: 9557634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine.
    Gahery H; Daniel N; Charmeteau B; Ourth L; Jackson A; Andrieu M; Choppin J; Salmon D; Pialoux G; Guillet JG
    AIDS Res Hum Retroviruses; 2006 Jul; 22(7):684-94. PubMed ID: 16831093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In a mixed subtype epidemic, the HIV-1 Gag-specific T-cell response is biased towards the infecting subtype.
    Geldmacher C; Currier JR; Gerhardt M; Haule A; Maboko L; Birx D; Gray C; Meyerhans A; Cox J; Hoelscher M
    AIDS; 2007 Jan; 21(2):135-43. PubMed ID: 17197803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
    Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
    J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection.
    Betts MR; Ambrozak DR; Douek DC; Bonhoeffer S; Brenchley JM; Casazza JP; Koup RA; Picker LJ
    J Virol; 2001 Dec; 75(24):11983-91. PubMed ID: 11711588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of human immunodeficiency virus (HIV)-specific CD8 T-cell responses by Listeria monocytogenes and a hyperattenuated Listeria strain engineered to express HIV antigens.
    Friedman RS; Frankel FR; Xu Z; Lieberman J
    J Virol; 2000 Nov; 74(21):9987-93. PubMed ID: 11024127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low or no antibody responses to human immunodeficiency virus type 1 Nef in infected carriers with subtype E, in contrast to subtype B that showed antibodies preferentially recognizing subtype-specific Nef epitopes.
    Komoto S; Kinomoto M; Ibrahim MS; Zhong Q; Auwanit W; Ayuthaya PI; Otake T; Mori H; Oishi I; Kurosu T; Takahashi H; Mukai T; Ikuta K
    Vaccine; 2001 Apr; 19(20-22):3019-32. PubMed ID: 11282214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals.
    Larsson M; Jin X; Ramratnam B; Ogg GS; Engelmayer J; Demoitie MA; McMichael AJ; Cox WI; Steinman RM; Nixon D; Bhardwaj N
    AIDS; 1999 May; 13(7):767-77. PubMed ID: 10357375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor recognition of HIV-1 Nef protein by CD8 T cells from HIV-1-infected children: impact of age.
    Buseyne F; Scott-Algara D; Corre B; Porrot F; Monchatre E; Bellal N; Burgard M; Rouzioux C; Blanche S; Rivière Y
    Virology; 2006 Oct; 354(2):271-9. PubMed ID: 16904156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of major histocompatibility class I on human dendritic cells by HIV Nef impairs antigen presentation to HIV-specific CD8+ T lymphocytes.
    Andrieu M; Chassin D; Desoutter JF; Bouchaert I; Baillet M; Hanau D; Guillet JG; Hosmalin A
    AIDS Res Hum Retroviruses; 2001 Sep; 17(14):1365-70. PubMed ID: 11602047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of HIV-specific CD8 T cells by in vitro stimulation with inactivated viral particles.
    Xu J; Whitman L; Lori F; Lisziewicz J
    AIDS; 2002 Sep; 16(14):1849-57. PubMed ID: 12351944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection.
    Dalod M; Dupuis M; Deschemin JC; Goujard C; Deveau C; Meyer L; Ngo N; Rouzioux C; Guillet JG; Delfraissy JF; Sinet M; Venet A
    J Clin Invest; 1999 Nov; 104(10):1431-9. PubMed ID: 10562305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-clade conservation of HIV type 1 Nef immunodominant regions recognized by CD8+ T cells of HIV type 1 CRF02_AG-infected Ivorian (West Africa).
    Inwoley A; Recordon-Pinson P; Dupuis M; Gaston J; Genête M; Minga A; Letourneur F; Rouet F; Choppin J; Fleury H; Guillet JG; Andrieu M;
    AIDS Res Hum Retroviruses; 2005 Jul; 21(7):620-8. PubMed ID: 16060833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic and proliferative T cell responses in HIV-1-infected Macaca nemestrina.
    Kent SJ; Corey L; Agy MB; Morton WR; McElrath MJ; Greenberg PD
    J Clin Invest; 1995 Jan; 95(1):248-56. PubMed ID: 7814622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.